Stemgent Obtains $11,299,993 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cfe4aea9-3f90-4638-b4d2-79cc4cfe7499&Preview=1 - Date
8/13/2012 - Company Name
Stemgent - Mailing Address
One Kendall Square B6201 Cambridge, MA 02139 - Company Description
Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world’s leading stem cell scientists. - Website
http://www.stemgent.com - Transaction Type
Venture Equity - Transaction Amount
$11,299,993 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
